北京同仁堂医养投资股份有限公司招股书申请版本

Application Proof of Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (A joint stock company incorporated in the People’s Republic of China with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “StockExchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providinginformation to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change whichcan be material. By viewing this document, you acknowledge, accept and agree with Beijing Tong Ren TangHealthcare Investment Co., Ltd. () (the “Company”), its sponsor, sole overallcoordinator, advisors and members of the underwriting syndicate that: (a)this document is only for the purpose of providing information about the Company to the public in Hong Kongand not for any other purposes. No investment decision should be based on the information contained in thisdocument;(b)the publication of this document or any supplemental, revised or replacement pages on the Stock Exchange’swebsite does not give rise to any obligation of the Company, its sponsor, sole overall coordinator, advisors ormembers of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.There is no assurance that the Company will proceed with any offering;(c)the contents of this document or any supplemental, revised or replacement pages may or may not be replicatedin full or in part in the actual final listing document;(d)this Application Proof is not the final listing document and may be updated or revised by the Company fromtime to time in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of HongKong Limited;(e)this document does not constitute a prospectus, offering circular, notice, circular, brochure or advertisementoffering to sell any securities to the public in any jurisdiction, nor is it an invitation to the public to make offersto subscribe for or purchase any securities, nor is it calculated to invite offers by the public to subscribe foror purchase any securities;(f)this document must not be regarded as an inducement to subscribe for or purchase any securities, and no suchinducement is intended;(g)neither the Company nor any of its affiliates, sponsor, sole overall coordinator, advisors or members of itsunderwriting syndicate is offering, or is soliciting offers to buy, any securities in any jurisdiction through thepublication of this document;(h)no application for the securities mentioned in this document should be made by any person nor would suchapplication be accepted;(i)the Company has not and will not register the securities referred to in this document under the United StatesSecurities Act of 1933, as amended, or any state securities laws of the United States;(j)as there may be legal restrictions on the publication of this document or dissemination of any informationcontained in this document, you agree to inform yourself about and observe any such restrictions applicableto you; and(k)the application to which this document relates has not been approved for listing and the Stock Exchange andthe Commission may accept, return or reject the application for the subject public offering and/or listing. No offer or invitation will be made to the public in Hong Kong until after a prospectus of the Company hasbeen registered with the Registrar of Companies in Hong Kong in accordance with the Companies (WindingUp and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). If an offer or aninvitation is made to the public in Hong Kong in due course, prospective investors are reminded to make theirinvestment decisions solely based on the Company’s prospectus registered with the Registrar of Companies inHong Kong, copies of which will be published to the public during the offer period. IMPORTANT Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (A joint stock company incorporated in the People’s Republic of China with limited liability) [REDACTED] Number of[REDACTED]underthe[REDACTED]:[REDACTED]H Shares (subject to the[REDACTED])Number of[REDACTED]:[REDACTED]H Shares (subject to[REDACTED])Number of[REDACTED]:[REDACTED]H Shares (subject to[REDACTED]and the[REDACTED])Maximum[REDACTED]:HK$[REDACTED]per H Share, plusbrokerage of 1.0%, SFC transactionlevy of 0.0027%, AFRC transactionlevy of 0.00015% and Stock Exchangetrading fee of 0.00565% (payable infull on application in Hong Kongdollars and subject to refund)Nominal Value:RMB1.00 per H ShareStock Code:[REDACTED] Sponsor,[REDACTED],[REDACTED],[REDACTED]and[REDACTED] Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of thisdocument, make no representation as to its accuracy or completeness and expressly disclaim any liabilit